Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours

Phase IIa study of HX009+ IN10018 in combination with or without standard chemotherapy in patients with advanced solid tumours including biliary tract malignancies and malignant melanoma

Participants needed: 124
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Hangzhou Hanx Biopharmaceuticals, Ltd.Updated: Apr 16, 2026Locations: 1
Eligibility criteria

Voluntarily participate in the trial and sign the informed consent form; [+4]

Histological or pathological diagnosis of carcinoma of the jugular abdomen; [+10]

Status: Recruiting

A Phase 2 Study of HX301 in Patients with High-grade Giloma

The study will include a dose-escalation and dose-expansion component to establish the recommended Phase 2 dose (RP2D) for HX301 in combination with Temozolomide and to evaluate the preliminary antitumor activity of HX301.HX301 is an investigational drug that has not yet been approved by the Food and Drug Administration (FDA) or any other regulatory authorities for commercial purposes.

Participants needed: 72
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Hangzhou Hanx Biopharmaceuticals, Ltd.Updated: Jan 15, 2025Locations: 1
Eligibility criteria

Signed informed consent form; [+9]

Part II: Patients with recurrent glioblastoma; [+6]